Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Plus Therapeutics (PSTV) Cost of Revenue (2016 - 2020)

Plus Therapeutics has reported Cost of Revenue over the past 10 years, most recently at $104000.0 for Q3 2020.

  • Quarterly Cost of Revenue rose 10.64% to $104000.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $482000.0 through Sep 2020, up 36.93% year-over-year, with the annual reading at $468000.0 for FY2019, 27.22% down from the prior year.
  • Cost of Revenue was $104000.0 for Q3 2020 at Plus Therapeutics, down from $105000.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $1.3 million in Q2 2017 and troughed at $47000.0 in Q4 2018.
  • The 5-year median for Cost of Revenue is $185000.0 (2018), against an average of $474631.6.
  • Year-over-year, Cost of Revenue tumbled 91.45% in 2018 and then soared 246.81% in 2019.
  • A 5-year view of Cost of Revenue shows it stood at $869000.0 in 2016, then plummeted by 36.71% to $550000.0 in 2017, then tumbled by 91.45% to $47000.0 in 2018, then soared by 246.81% to $163000.0 in 2019, then tumbled by 36.2% to $104000.0 in 2020.
  • Per Business Quant, the three most recent readings for PSTV's Cost of Revenue are $104000.0 (Q3 2020), $105000.0 (Q2 2020), and $110000.0 (Q1 2020).